These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 16322309

  • 1. FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma.
    Lee TK, Man K, Ho JW, Wang XH, Poon RT, Xu Y, Ng KT, Chu AC, Sun CK, Ng IO, Sun HC, Tang ZY, Xu R, Fan ST.
    Clin Cancer Res; 2005 Dec 01; 11(23):8458-66. PubMed ID: 16322309
    [Abstract] [Full Text] [Related]

  • 2. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis].
    Li Y, Tang ZY, Wang L, Yao Z, Lu R, Xue Q, Gao DM, Chen J.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 17; 84(8):675-9. PubMed ID: 15130313
    [Abstract] [Full Text] [Related]

  • 3. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
    Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, Sun CK, Poon RT, Fan ST.
    Clin Cancer Res; 2010 Feb 01; 16(3):967-77. PubMed ID: 20103676
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 5. Suppression of hepatocellular carcinoma recurrence after rat liver transplantation by FTY720, a sphingosine-1-phosphate analog.
    Ushitora Y, Tashiro H, Ogawa T, Tanimoto Y, Kuroda S, Kobayashi T, Miyata Y, Itamoto T, Asahara T, Ohdan H.
    Transplantation; 2009 Oct 27; 88(8):980-6. PubMed ID: 19855243
    [Abstract] [Full Text] [Related]

  • 6. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q.
    J Cancer Res Clin Oncol; 2003 Jan 27; 129(1):43-51. PubMed ID: 12618900
    [Abstract] [Full Text] [Related]

  • 7. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
    Wang Z, Fan J, Zhou J, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 27; 86(24):1666-70. PubMed ID: 16854316
    [Abstract] [Full Text] [Related]

  • 8. Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target.
    Lee TK, Man K, Ho JW, Wang XH, Poon RT, Sun CK, Ng KT, Ng IO, Xu R, Fan ST.
    Carcinogenesis; 2005 Mar 27; 26(3):681-7. PubMed ID: 15604094
    [Abstract] [Full Text] [Related]

  • 9. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models.
    Azuma H, Takahara S, Ichimaru N, Wang JD, Itoh Y, Otsuki Y, Morimoto J, Fukui R, Hoshiga M, Ishihara T, Nonomura N, Suzuki S, Okuyama A, Katsuoka Y.
    Cancer Res; 2002 Mar 01; 62(5):1410-9. PubMed ID: 11888913
    [Abstract] [Full Text] [Related]

  • 10. Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway.
    Ng KT, Man K, Ho JW, Sun CK, Lee TK, Zhao Y, Lo CM, Poon RT, Fan ST.
    Int J Oncol; 2007 Feb 01; 30(2):375-80. PubMed ID: 17203219
    [Abstract] [Full Text] [Related]

  • 11. FTY720 inhibits tumor growth and angiogenesis.
    Schmid G, Guba M, Papyan A, Ischenko I, Brückel M, Bruns CJ, Jauch KW, Graeb C.
    Transplant Proc; 2005 Feb 01; 37(1):110-1. PubMed ID: 15808563
    [Abstract] [Full Text] [Related]

  • 12. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
    Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Tang ZY.
    Clin Cancer Res; 2008 Aug 15; 14(16):5124-30. PubMed ID: 18698030
    [Abstract] [Full Text] [Related]

  • 13. High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential.
    Wang L, Tang ZY, Qin LX, Wu XF, Sun HC, Xue Q, Ye SL.
    Hepatology; 2000 Jul 15; 32(1):43-8. PubMed ID: 10869287
    [Abstract] [Full Text] [Related]

  • 14. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.
    Chua CW, Chiu YT, Yuen HF, Chan KW, Man K, Wang X, Ling MT, Wong YC.
    Clin Cancer Res; 2009 Jul 01; 15(13):4322-35. PubMed ID: 19509141
    [Abstract] [Full Text] [Related]

  • 15. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G, Guba M, Ischenko I, Papyan A, Joka M, Schrepfer S, Bruns CJ, Jauch KW, Heeschen C, Graeb C.
    J Cell Biochem; 2007 May 01; 101(1):259-70. PubMed ID: 17203465
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous intratumoral injection of traditional Chinese herbal compound medicine Star-99 in treatment of hepatocellular carcinoma of mice.
    Lin LW, Sun Y, He YM, Gao SD, Xue ES, Lin XD, Yu LY, Lin XF, Yang YH.
    Hepatobiliary Pancreat Dis Int; 2004 Feb 01; 3(1):49-54. PubMed ID: 14969837
    [Abstract] [Full Text] [Related]

  • 17. Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice.
    Yang BW, Liang Y, Xia JL, Sun HC, Wang L, Zhang JB, Tang ZY, Liu KD, Chen J, Xue Q, Chen J, Gao DM, Wu WZ.
    Eur J Gastroenterol Hepatol; 2008 Nov 01; 20(11):1077-84. PubMed ID: 19047839
    [Abstract] [Full Text] [Related]

  • 18. [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
    Li Y, Tang Z, Ye S, Liu Y, Chen J, Xue Q, Huang X, Chen J, Bao W, Yang J, Gao D.
    Zhonghua Yi Xue Za Zhi; 2002 May 10; 82(9):601-5. PubMed ID: 12133480
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
    Zhang T, Sun HC, Xu Y, Zhang KZ, Wang L, Qin LX, Wu WZ, Liu YK, Ye SL, Tang ZY.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8557-63. PubMed ID: 16361537
    [Abstract] [Full Text] [Related]

  • 20. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
    Pchejetski D, Bohler T, Brizuela L, Sauer L, Doumerc N, Golzio M, Salunkhe V, Teissié J, Malavaud B, Waxman J, Cuvillier O.
    Cancer Res; 2010 Nov 01; 70(21):8651-61. PubMed ID: 20959468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.